Duncker Streett & Co’s Organon & Co OGN Stock Holding History

Duncker Streett & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-42	Closed	-$407	–	542
2025 Q2	$407	Buy	+42	New	+$433	﹤0.01%	501
2024 Q4	–	Sell	-80	Closed	-$1.53K	–	549
2024 Q3	$1.53K	Hold	80	–	–	﹤0.01%	455
2024 Q2	$1.66K	Hold	80	–	–	﹤0.01%	454
2024 Q1	$1.5K	Hold	80	–	–	﹤0.01%	453
2023 Q4	$1.15K	Hold	80	–	–	﹤0.01%	463
2023 Q3	$1.39K	Hold	80	–	–	﹤0.01%	459
2023 Q2	$1.67K	Sell	80 -20	-20%	-$435	﹤0.01%	464
2023 Q1	$2.35K	Hold	100	–	–	﹤0.01%	442
2022 Q4	$2.79K	Sell	100 -287	-74%	-$7.34K	﹤0.01%	459
2022 Q3	$9K	Sell	387 -20	-5%	-$604	﹤0.01%	401
2022 Q2	$14K	Hold	407	–	–	﹤0.01%	393
2022 Q1	$14K	Sell	407 -160	-28%	-$5.47K	﹤0.01%	400
2021 Q4	$17K	Sell	567 -600	-51%	-$19.5K	﹤0.01%	424
2021 Q3	$38K	Buy	1,167 +395	+51%	+$12.6K	0.01%	355
2021 Q2	$23K	Buy	+772	New	+$25.4K	﹤0.01%	397

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Duncker Streett & Co's OGN Position: Q3 2025 in Review

Duncker Streett & Co sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 42 shares — an estimated $407 sold.

Duncker Streett & Co first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $38K in Q3 2021. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

Duncker Streett & Co reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
Duncker Streett & Co sold 42 Organon & Co shares in Q3 2025, an estimated $407.
Duncker Streett & Co first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
Duncker Streett & Co's Organon & Co position peaked at $38K in Q3 2021.
670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Duncker Streett & Co's 13F filing for Q3 2025, filed 23 Oct 2025.